Increasing Adoption Of Personalized Medicine Drives Growth In The Pharmacovigilance And Drug Safety Software Market: Major Factor in the Transformation of the Pharmacovigilance And Drug Safety Software Market in 2025

"How Will the Pharmacovigilance And Drug Safety Software Market Grow, and What Is the Projected Market Size?
The market size of pharmacovigilance and drug safety software has experienced rapid expansion in the past few years. The market is projected to escalate from $2.26 billion in 2024 to $2.55 billion in 2025, experiencing a compound annual growth rate (CAGR) of 13.2%. The previous growth can be a result of the boosted demand for this particular type of software.

The market size of pharmacovigilance and drug safety software is anticipated to expand rapidly in the upcoming years, estimating a size of $4.15 billion by 2029 at a compound annual growth rate (CAGR) of 12.9%. The upsurge during the predicted period is due to factors like an increase in instances of adverse drug reactions and the worldwide expansion of pharmacovigilance, escalation in adverse drug reactions, more complex drug safety guidelines, advancements in the creation of new drugs and therapies, and a rise in adverse drug reactions (ADRs). The major trends expected for the forecast period incorporate the integration of automation and AI, cloud-based solutions, technological advancements, enhancements in technology, and a surge in healthcare digitalization.

What Key Elements Are Boosting Growth in the Pharmacovigilance And Drug Safety Software Market?
Anticipated expansion in the field of pharmacovigilance and drug safety software market is largely fueled by the increasing interest in personalized medicine. This contemporary approach to medical treatment regards each patient as distinctly individual and offers tailored healthcare options and treatments. The rising trend towards personalized medicine can be attributed to its key benefits, including its effectiveness in handling individual health needs, its emphasis on early prevention and detection, and its cost-effective solutions. The crux of personalized medicine lies in efficient pharmacovigilance and drug safety software, which play a critical role in maintaining the highest safety and efficiency levels of custom treatments. These software systems integrate different elements like pharmacogenetics, immediate data analysis, post-marketing surveillance, and personalized drug information, enhancing individual therapies' safety while ensuring stringent risk management practices and addressing ethical considerations. For instance, stats from the Personalized Medicine Coalition, a non-profit organization in the US, showed that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, in comparison to just 6 in the previous year. Consequently, the escalating need for personalized medicine serves as a driving force behind the pharmacovigilance and drug safety software market's growth.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19140&type=smp

Who Are the Major Industry Players Fueling Pharmacovigilance And Drug Safety Software Market Expansion?
Major companies operating in the pharmacovigilance and drug safety software market are, International Business Machines Corporation, Deloitte Touche Tohmatsu Limited, Oracle Corporation, Capgemini SE, Cognizant Technology Solutions, IQVIA, Wipro Limited, Genepact, Parexel Academy, PharmaLex, Indegene Limited, RXLogix, Sarjen Systems Pvt Ltd., Anju Software Inc., Ennov Group, EXTEDO GmbH, ArisGlobal, AB Cube, Clinevo Technologies

Which Key Developments Are Influencing the Pharmacovigilance And Drug Safety Software Market?
Key players in the pharmacovigilance and drug safety software market are pioneering new technologies like cloud-based data lake platforms to ensure greater patient safety, better monitor adverse events, and uphold regulatory compliance in clinical trials and post-market medical device surveillance. These cloud-based data lake platforms are scalable, centralized storage systems that make it possible to store, handle, and scrutinize large quantities of organized and unorganized data. They offer up-to-the-minute data access and accommodate advanced analytics as well as AI/ML workloads. For example, Thermo Fisher Scientific Inc., a biotech firm based in the US, unveiled CorEvidence in December 2023. This cutting-edge, proprietary cloud-based data lake platform is created to boost pharmacovigilance operations within clinical research registries, specifically targeting the optimization of case processing and safety data management for post-authorization safety studies.

How Is the Segmentation of the Pharmacovigilance And Drug Safety Software Market Defined?
The pharmacovigilance and drug safety softwaremarket covered in this report is segmented -

1) By Software Type: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software
2) By Delivery Mode: On-premise, Cloud-based
3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users

Subsegments:
1) By Adverse Event Reporting Software: Spontaneous Reporting Systems, EHR Integration Solutions, Mobile Reporting Applications
2) By Drug Safety Audits Software: Audit Management Solutions, Compliance Tracking Tools, Reporting And Analytics Modules
3) By Issue Tracking Software: Incident Reporting Systems, Workflow Management Tools, Collaboration Platforms
4) By Fully Integrated Software: Pharmacovigilance Platforms, Regulatory Compliance Systems, Data Analytics And Visualization Tools

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/pharmacovigilance-and-drug-safety-software-global-market-report

What Is the Leading Region in the Pharmacovigilance And Drug Safety Software Market?
North America was the largest region in the pharmacovigilance and drug safety software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Pharmacovigilance And Drug Safety Software Global Market Report?

- Market Size Analysis: Analyze the Pharmacovigilance And Drug Safety Software Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Pharmacovigilance And Drug Safety Software Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Pharmacovigilance And Drug Safety Software Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Pharmacovigilance And Drug Safety Software Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19140

"

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.